Tagged with R

Dr Reddy's Laboratories Australia Dr. Reddy’s entered Australia under your leadership. Would you outline the key milestones & achievements? Our first product was available to us for commercialization in Jan 2010 and since then we have grown rapidly on several parameters , about 1000 community pharmacies buy Dr.Reddy’s products directly , we also work…

TranScrip Partners Senior Partner Dr Sree Haran has also participated in this interview. TranScrip Partners is by now a well-established player in the UK but a new player in Asia Pacific. Would you begin by introducing TranScrip Partners to our readers? Dr. Sree Haran: TranScrip Partners was founded in 2008, and differs…

Ferring - Belgium This August marks your sixth year at the helm of the Belgian affiliate of Ferring, what would you say best explains your loyalty to the company? One element that appeals to me about Ferring is that it offers a perfect compromise between entrepreneurial spirit and multinational scope which I believe…

Mexican Diabetes Federation Could you give us a brief introduction to the Federacion Mexicana de Diabetes? The Mexican Diabetes Federation was established in 1988 by a group of people affected by diabetes, as well as families and health professionals interested in tackling this disease in a more effective and preventive way Nowadays our…

P&G Singapore Innovation Center (SgIC) Why did P&G decide to set up the center in Singapore? There are several reasons why P&G decided on Singapore. First, we wanted to reach more consumers, particularly in emerging markets; Singapore is very central to that. From Singapore we can reach 2/3 of the world’s population within a 6…

Spar Todopromo Mexico In 2011, Todopromo decided to join forces with Spar, an American company specialized in merchandising and points of sale solutions. After remaining for many years as a self-run company, how did you experience this new joint venture? It has been great and we are proud to be part of a…

CECyC Pharma Mexico With the new drug registration laws that were announced in 2005, was CECyC Pharma initiated as result of this new law, or pre-emptively because you saw that the market was due to change? We started operations in 2005 as an authorized third party bioequivalence and clinical trials center. Companies like…

Array   After just six months in the country, Novartis Australia’s new Managing Director offers his perspectives on the Australian pharmaceutical market and healthcare system, his company’s commitment to R&D, and Australia’s competitiveness for clinical trials in the Asian context. You arrived in July 2012 after working in different positions for…

BRASS Biomedical Research and Support Services Pte Ltd. is an NUS University spin-off that has been around for more than 14 years; last year the company name was changed to BRASS. Why was this decision taken and what is the new image that Brass wants to project to the industry? We…

Leo Pharma Austria You have been managing LEO Pharma’s Austrian operations since March 2012. How do you look back at these first few months? And what have been your first initiatives at the head of the affiliate? 2012 has overall been an interesting year, as LEO Pharma stepped into new fields of indication…

Baker & Mckenzie Mexico The regulatory framework in Mexico is in constant change, and pharmaceutical com-panies are struggling to comply. What sort of challenges are companies facing when deal-ing with COFEPRIS and what must be achieved? Permanent legal uncertainty and lack of transparency are the main challenges to re-solve. The first step would be…

Novo Nordisk - Australia Can you start by commenting on the state of diabetes in Australia at present? According to 2011 statistics nearly one million Australians have diabetes and about half of those are not aware that they have the condition. Australia is ranked 7th in the world in terms of prevalence of type…